Skip to main content Accessibility help
×
  1. Home
  2. Publications
  3. Journals
  4. Content listing

Refine listing

Refine listing

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

2100844 results in Journals

Page 360 of 105043

  • A Just Transgression of AMR Governance? How Mexico City’s Informal Medicine Sellers Balance Antibiotic Care and Control by Bending the Rules

  • Part of
  • Rodrigo Rangel-Gutiérrez, René Gerrets
  • Journal:
    Public Humanities / Volume 2 / 2026
    Published online by Cambridge University Press:
    19 February 2026, e17
    • Article
      • You have access
      • Open access
    • PDF
    • HTML
    • Export citation

  • This article explores how informal medicine sellers (IMSs) in Mexico City “contest” and “reassemble” antibiotic control standards in ways that both challenge and respond to antimicrobial resistance (AMR) governance. Drawing on ethnographic fieldwork, we examine the “rationales”—moral, political, economic, technoscientific, and practical—that IMSs invoke to justify bypassing antibiotic prescription, dispensing and accounting regulations, and the “practical tinkering” they perform to make antibiotics available and “appropriately” used under conditions of scarcity and oversight failure. Rather than viewing IMSs as simply breaking official rules, we adopt a “social life of standards” perspective to argue that their actions reflect localized enactments of antibiotic control—versions shaped by community needs, corruption, poverty, and distrust in public health infrastructures. These practices are ambivalent, blurring boundaries between public service and profit and systemic subversion and informal regulation. By tracking how IMSs adapt, collectivize, and sometimes deliver treatments, we show how antibiotic governance is reworked from below—not only in response to AMR, but also to structural exclusions from formal care. We argue that rather than treating IMS rationales and practices as part of the problem, they should be studied as grounded responses to systemic failure—and potential sources of insight for context-sensitive regulatory design.

Page 360 of 105043